Elevated levels of damage-associated molecular patterns HMGB1 and S100A8/A9 coupled with toll-like receptor-triggered monocyte activation are associated with inflammation in patients with myelofibrosis.
Humans
HMGB1 Protein
/ blood
Calgranulin A
/ blood
Calgranulin B
/ blood
Male
Female
Monocytes
/ immunology
Aged
Middle Aged
Alarmins
/ metabolism
Inflammation
/ immunology
Primary Myelofibrosis
/ immunology
Aged, 80 and over
Toll-Like Receptors
/ metabolism
Cytokines
/ metabolism
Adult
Toll-Like Receptor 4
/ metabolism
Biomarkers
HMGB1
S100A8/A9
Toll-like receptors
inflammation
monocyte
myelofibrosis
Journal
Frontiers in immunology
ISSN: 1664-3224
Titre abrégé: Front Immunol
Pays: Switzerland
ID NLM: 101560960
Informations de publication
Date de publication:
2024
2024
Historique:
received:
03
01
2024
accepted:
26
08
2024
medline:
11
10
2024
pubmed:
11
10
2024
entrez:
11
10
2024
Statut:
epublish
Résumé
Inflammation plays a pivotal role in the pathogenesis of primary and post-essential thrombocythemia or post-polycythemia vera myelofibrosis (MF) in close cooperation with the underlying molecular drivers. This inflammatory state is induced by a dynamic spectrum of inflammatory cytokines, although recent evidence points to the participation of additional soluble inflammatory mediators. Damage-associated molecular patterns (DAMPs) represent endogenous signals released upon cell death or damage which trigger a potent innate immune response. We assessed the contribution of two prototypical DAMPs, HMGB1 and S100A8/A9, to MF inflammation. Circulating HMGB1 and S100A8/A9 were elevated in MF patients in parallel to the degree of systemic inflammation and levels increased progressively during advanced disease stages. Patients with elevated DAMPs had higher frequency of adverse clinical features, such as anemia, and inferior survival, suggesting their contribution to disease progression. Monocytes, which are key players in MF inflammation, were identified as a source of S100A8/A9 but not HMGB1 release, while both DAMPs correlated with cell death parameters, such as serum LDH and cell-free DNA, indicating that passive release is an additional mechanism leading to increased DAMPs. HMGB1 and S100A8/A9 promote inflammation through binding to Toll-like receptor (TLR) 4, whereas the former also binds TLR2. Monocytes from MF patients were shown to be hyperactivated at baseline, as reflected by higher CD11b and tissue factor exposure and increased expression levels of proinflammatory cytokines IL-1β and IL-6. Patient monocytes showed preserved TLR4 and TLR2 expression and were able to mount normal or even exacerbated functional responses and cytokine upregulation following stimulation of TLR4 and TLR2. Elevated levels of endogenous TLR ligands HMGB1 and S100A8/A9 coupled to the finding of preserved or hyperreactive TLR-triggered responses indicate that DAMPs may promote monocyte activation and cytokine production in MF, fueling inflammation. Plasma IL-1β and IL-6 were elevated in MF and correlated with DAMPs levels, raising the possibility that DAMPs could contribute to cytokine generation
Identifiants
pubmed: 39391311
doi: 10.3389/fimmu.2024.1365015
pmc: PMC11465240
doi:
Substances chimiques
HMGB1 Protein
0
Calgranulin A
0
Calgranulin B
0
S100A8 protein, human
0
HMGB1 protein, human
0
S100A9 protein, human
0
Alarmins
0
Toll-Like Receptors
0
Cytokines
0
Toll-Like Receptor 4
0
Biomarkers
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
1365015Informations de copyright
Copyright © 2024 De Luca, Goette, Lev, Baroni Pietto, Marin Oyarzún, Castro Ríos, Moiraghi, Sackmann, Kamiya, Verri, Caula, Fernandez, Vicente, Pose Cabarcos, Caruso, Camacho, Larripa, Khoury, Marta, Glembotsky and Heller.
Déclaration de conflit d'intérêts
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.